| Literature DB >> 15122733 |
Steven Snapinn1, Thomas Cook, Deborah Shapiro, Duane Snavely.
Abstract
In clinical trials sponsored by Merck the unblinded statistician is typically an employee of the company. From a pharmaceutical industry perspective, advantages of this approach include ensuring that the unblinded statistician is knowledgeable regarding the experimental treatments, therapeutic area and study objectives; that the quality of the analysis conforms to rigorous standards; and that the allocation schedule, database and interim results are kept confidential. These advantages are felt to outweigh any potential disadvantages. Copyright 2004 John Wiley & Sons, Ltd.Keywords: Biomedical and Behavioral Research
Mesh:
Year: 2004 PMID: 15122733 DOI: 10.1002/sim.1790
Source DB: PubMed Journal: Stat Med ISSN: 0277-6715 Impact factor: 2.373